2015 annual financial data

Rigel Pharmaceuticals, Inc. 2015 Operating margin

Rigel Pharmaceuticals, Inc. 2015 operating margin with verified reported values.

Direct answer

Operating margin was -179.07%.

Operating income was -51,743,000 USD and net income was -51,464,000 USD.
Operating cash flow was -23,413,000 USD.

Get free Rigel Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
28,895,000 USD
Operating income
-51,743,000 USD
Net income
-51,464,000 USD
Operating cash flow
-23,413,000 USD